Pixel Watch 3 gets FDA approval for Loss of Pulse Detection in US

What you need to know

  • The FDA has signaled approval for the Loss of Pulse Detection feature on the Pixel Watch 3.
  • It detects if the user is experiencing “primary cardiac arrest” or “respiratory or circulatory failure.”
  • Loss of Pulse Detection was previously available in 14 European countries, but will not arrive in the U.S. until late March 2025.

A key draw to the Pixel Watch 3 is its Fitbit-branded health sensors for detecting heart issues. On Wednesday, Google announced that the FDA has given clearance for Loss of Pulse Detection to be used on its smartwatch in the United States, signaling that the feature is accurate enough to be trusted on a consumer device.

As the name implies, Loss of Pulse Detection can “detect when you’ve experienced a loss of pulse.” It will then vibrate with a check-in message before starting an alarm to alert people nearby; if you continue to be unresponsive, it will attempt to call 911 and send an automated message with your location to the emergency responder.

Leave a Reply

Your email address will not be published. Required fields are marked *